[TGTX]
Mid
Mid
2026-08-21 23:07:00
TG Therapeutics gains amid takeover speculation
Row
2026-08-04 03:39:00
TG Therapeutics down 11% following Q2 bottom line miss
Mid
2026-08-04 00:52:11
TG Therapeutics targets $890M-$905M 2026 U.S. BRIUMVI net revenue while anticipating subcutaneous Phase III results around year-end
Row
2026-08-03 20:07:43
TG Therapeutics GAAP EPS of $0.05 misses by $0.26, revenue of $240.34M beats by $10.55M
Row
2026-07-31 23:39:14
TG Therapeutics Q2 2026 Earnings Preview